쥐의 척수강 내로 투여한 Phosphodiesterase 억제제인 Zaprinast의 포르말린 유발 통증 반응 및 혈역학에 대한 영향 = Effect of Zaprinast, a Phosphodiesterse Inhibitor, on Formalin-induced Nociception and Hemodynamicsin the Rat Spinal Cord

다국어 초록 (Multilingual Abstract)

Background: Cyclic guanosine monophosphate (cGMP) is involved in antinociception and vascular relaxation. The effects of zaprinast, which increases the level of cGMP by inhibiting phosphodiesterase, in the spinal cord have not been reported. The aims of this study were to evaluate the effects of intrathecal zaprinast on stimulus evoked by formalin injection, and to observe hemodynamic change in the absence of formalin stimulation.
Methods: Rats were implanted with lumbar intrathecal catheters. Intrathecal zaprinast was administered 10 min before formalin injection. After formalin injection, formalin-induced nociceptive behavior (flinching response) was observed for 60 min. Mean arterial pressure (MAP) and heart rate (HR) were measured after intrathecal delivery of zaprinast for a period of 60 min.
Results: Intrathecal administration of zaprinast produced a dose-dependent suppression of flinches in both phases. Zaprinast had no evident effects on baseline MAP or HR.
Conclusions: Zaprinast, a phosphodiesterase inhibitor, is active against the nociceptive state evoked by formalin stimulus without affecting resting MAP or HR. Accordingly, spinal zaprinast may be useful in the management of tissue-injury induced pain.

참고문헌 (Reference)

1 "the peripheral analgesic activity of morphine" prostaglandins1979191-200

2 "cGMP signal termination" 24 : 1019-22, 1996

3 "The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway" 73 : 649-55, 1996

4 "The L-arginine-nitric oxide pathway" 329 : 2002-12, 1993

5 "Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway" 909 : 170-8, 2001

6 "Sildenafil,a phosphodiesterase-5 inhibitor,enhances the antinociceptive effect ofmorphine" 67 : 150-6, 2003

7 "Sildenafil produces antinociception and increases morphine antinociception in the formalin test" 400 : 81-7, 2000

8 "Sildenafil increases diclofenac antinociception in the formalin test" 418 : 195-200, 2001

9 "Sildenafil citrate,a selective phosphodiesterase type 5 Inhibitor" 10 : 97-104, 1999

10 "Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors" 11 : 150-5, 1990

11 "Pharmacology of spinal afferent processing Edited by Yaksh TL" Lippincott-Raven Publishers 557-76, 1997

12 "Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia" 127 : 671-8, 1999

13 "Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway" 186 : 289-93, 1990

14 "Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase(PDE5)" 247 : 249-54, 1998

15 "Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception" 69 : 183-9, 2003

16 "Manual of pharmacologic calculations with computer programs" New York,Springer-Verlag 1-95, 1987

17 "L-NAME,a nitric oxide synthase inhibitor,modulates cholinergic antinociception" 21 : 161-5, 1999

18 "Inducible nitric oxide synthase: what difference does it make?" 2417-23, 1997

19 "Endogenous activating factor for guanylate cyclase in synaptosomal-soluble fraction of rat brain" 252 : 7617-9, 1977

20 "Effect of sildenafil on human hemodynamics" 1999

21 "Cyclic nucleotide phosphodiesterases:functional implications of multiple isoforms" 75 : 725-48, 1995

22 "Chronic catheterization of the spinal suba-rachnoid space" 17 : 1031-6, 1976

23 "Characteristic of interactions between intrathecal gabapentin and either clonidine or neostigmine in the formalin test" 98 : 1374-9, 2004